Drug & intervention

rotigotine

RxCUI 616739

Clinical trials29
Recruiting0
Related conditions11
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

29 shown
Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms ManagementNCT03103919 · 2017-03-16
COMPLETED
Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable SensorsNCT03098368 · 2016-09-01
UNKNOWN
Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's DiseaseNCT02728947 · 2016-05-01
COMPLETED
Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of DiseaseNCT02103465 · 2013-12-01
TERMINATED
Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And ApathyNCT01782222 · 2013-02-01
COMPLETED
MIRT and Rotigotine in the Early Stage of PDNCT02100176 · 2013-01-01
UNKNOWN
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated PainNCT01744496 · 2012-11-01
COMPLETED
A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's DiseaseNCT01723904 · 2012-10-01
COMPLETED
A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's DiseaseNCT01711866 · 2012-09-01
COMPLETED
Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease PatientsNCT01646268 · 2012-07-01
COMPLETED
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease PatientsNCT01646255 · 2012-07-01
COMPLETED
Non Motors Aspects in De Novo Parkinson's DiseaseNCT02786667 · 2012-06-01
UNKNOWN
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease PatientsNCT01523301 · 2012-04-01
COMPLETED
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal DysfunctionNCT01536015 · 2012-01-01
TERMINATED
Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor SymptomsNCT01300819 · 2011-02-01
COMPLETED
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing SurgeryNCT00594464 · 2007-09-01
COMPLETED
Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal PatchNCT00522379 · 2007-07-01
COMPLETED
Safety and Tolerability Trial of Switching From Ropinirole to RotigotineNCT00593606 · 2007-07-01
COMPLETED
Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseNCT00519532 · 2007-07-01
TERMINATED
Randomized Evaluation of the 24-Hour Coverage: Efficacy of RotigotineNCT00474058 · 2007-05-01
COMPLETED
Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean SubjectsNCT01964573 · 2006-12-01
COMPLETED
Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's DiseaseNCT00292227 · 2006-01-01
COMPLETED
An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseNCT00505687 · 2005-02-01
COMPLETED
A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's DiseaseNCT00243945 · 2004-12-01
COMPLETED
A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's DiseaseNCT00242008 · 2004-12-01
COMPLETED
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's DiseaseNCT00501969 · 2004-08-01
COMPLETED
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's DiseaseNCT00599196 · 2002-08-01
COMPLETED
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's DiseaseNCT00594386 · 2002-08-01
COMPLETED
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.NCT00594165 · 2002-06-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.